About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Fake Journals - But They'd Like Real Money | Main | Novartis Loses the Glivec Patent Fight in India »

April 1, 2013

ChemBark Closing Down (Update: Not Really!)

Email This Entry

Posted by Derek

Looks like the long-running ChemBark blog is shutting down. Paul Bracher has a new academic position to get off the ground, a move to another part of the country, labs to set up, and grant applications to write, all of which are good enough reasons by themselves. I hope that once he gets settled into the new position that he returns to the chem-blogging world under a new banner - his site has been well worth reading over the years.

Update: I see Paul has come clean this afternoon in the comments section to his post. Congratulations to him on a very convincing April 1 job - I now, naturally, retract all the nice things I said about him (!)

Comments (7) + TrackBacks (0) | Category: Chemical News


1. Chemjobber on April 1, 2013 8:51 AM writes...

Might it be related to the date?

Permalink to Comment

2. See Arr Oh on April 1, 2013 8:58 AM writes...

@CJ - I thought that, too, but the closed comments section might be tell-tale...

Permalink to Comment

3. D-Not on April 1, 2013 9:42 AM writes...

Novartis loses landmark drug patent battle in India.

India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines.

Ranjit Shahani, the vice chairman and managing director of Novartis India, said the ruling "will hinder medical progress for diseases without effective treatment options" Humbug.

Permalink to Comment

4. Texas Forever on April 1, 2013 10:13 AM writes...

Boo. I hope he comes back. The field can always use a site like his. If only for the Nobel odds. Heh

Permalink to Comment

5. Curious Wavefunction on April 1, 2013 10:21 AM writes...

If it was an April Fools' prank it was a good one. I offered my condolences to him on Twitter.

Permalink to Comment

6. Chemjobber on April 1, 2013 3:49 PM writes...

Click on my handle to see that Paul was just keeeeding.

Permalink to Comment

7. Lu on April 3, 2013 2:57 PM writes...

Wow, getting a job sounds like a joke. What world we are living in?

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry